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Should analyses of large, national palliative
care data sets with patient reported
outcomes (PROs) be restricted to services
with high patient participation? A register-
based study
Maiken Bang Hansen1,2* , Morten Aagaard Petersen1, Lone Ross1 and Mogens Groenvold2
Abstract
Background: There is an increased interest in the analysis of large, national palliative care data sets including
patient reported outcomes (PROs). No study has investigated if it was best to include or exclude data from services
with low response rates in order to obtain the patient reported outcomes most representative of the national
palliative care population. Thus, the aim of this study was to investigate whether services with low response rates
should be excluded from analyses to prevent effects of possible selection bias.
Methods: Data from the Danish Palliative Care Database from 24,589 specialized palliative care admittances of
cancer patients was included. Patients reported ten aspects of quality of life using the EORTC QLQ-C15-PAL-
questionnaire. Multiple linear regression was performed to test if response rate was associated with the ten aspects
of quality of life.
Results: The score of six quality of life aspects were significantly associated with response rate. However, in only
two cases patients from specialized palliative care services with lower response rates (< 20.0%, 20.0–29.9%, 30.0–
39.9%, 40.0–49.9% or 50.0–59.9) were feeling better than patients from services with high response rates (≥60%)
and in both cases it was less than 2 points on a 0–100 scale.
Conclusions: The study hypothesis, that patients from specialized palliative care services with lower response rates
were reporting better quality of life than those from specialized palliative care services with high response rates,
was not supported. This suggests that there is no reason to exclude data from specialized palliative care services
with low response rates.
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Background
It has been shown that not all symptoms in advanced can-
cer patients admitted to palliative care are recognized by
the health care professionals. Systematic symptom assess-
ment has been proposed as a solution to this problem [1–
3]. Therefore, starting in 2010, cancer patients in all spe-
cialized palliative care (SPC) services in Denmark have
been invited to complete the European Organisation for
Research and Treatment of Cancer Quality of Life
Questionnaire-Core-15-Palliative Care questionnaire
(EORTC QLQ-C15-PAL) at the start of SPC. The ques-
tionnaire assesses different quality of life aspects of cancer
patients in palliative care, i.e., nine symptoms and prob-
lems and overall QOL. There is increasing interest in the
analysis of large, national data sets from palliative care
with patient reported outcomes (PROs). Thus, we planned
to analyze these patient reported QOL data to get a better
understanding of cancer patients’ QOL at the start of SPC
on a national level. However, the response rates varied to
a large extent between the SPC services in Denmark. This
led to a dilemma: we were concerned that the data from
palliative services with low response rate might be affected
by selection bias (e.g., if fewer of the most symptomatic
patients were included, the resulting scores would not be
representative). On the other hand, excluding some of the
SPC services from the dataset, would lead to reduced
generalizability of our study findings: we would not be
reporting national data but data from ‘well-performing
services’ only. And if excluding services, where should the
cutoff for exclusion be?
Some studies on patients with advanced cancer and in
palliative care have found that health affected study par-
ticipation [4, 5]: lower performance score and more pain
were associated with a lower probability of answering a
questionnaire [4] and non-respondents had lower phys-
ical performance and shorter survival than respondents
[5]. However, a third study in patients with advanced
cancer found no indication of clinically relevant differ-
ences in the quality of life scores when observed scores
were compared to scores that included imputed data,
and thus found no indication of bias due to non-
participation [6]. Thus, non-respondents would likely ei-
ther be similar or in worse health compared to
respondents.
Since patients admitted to SPC are severely ill and
close to death, it is not feasible for all patients to report
their symptoms/problems. However, if research is to give
an understanding of different aspects of QOL (symp-
toms, problems and overall QOL, in the following gener-
ally referred to as QOL) at the start of SPC it is crucial
to obtain QOL reporting from as representative a sample
as possible. If better QOL-scores are reported in SPC
services with low response rates it could be because only
the most well patients (i.e. those who were easiest to
obtain QOL reporting from) were asked to report their
QOL. In this case, the QOL scores from SPC services
with low response rates would probably be biased and
thus overestimate QOL, and one could argue that a
more correct estimate of QOL could be obtained if ser-
vices with low response rates were excluded from future
analyses.
Therefore, in this study, we wished to test the hypoth-
esis: Patients from SPC services with low response rates
report (on average) better on different QOL aspects than
patients from services with high response rates, indicating
a (larger) impact of selection bias in services with low re-
sponse rates than in services with high response rates.
Thus, although it is impossible to rule out selection bias
even in services with quite high response rates, we as-
sumed that differences in average scale scores between
services with low and high response rates could reflect
possible selection bias in the services with low response.
Thus, the aim of this study was to test whether re-
sponse rate was associated with the level of different
QOL aspects (i.e., with the level of the nine symptoms
and problems and overall QOL from the EORTC QLQ-
C15-PAL questionnaire).
If our study hypothesis was rejected and no indication
of bias was found, there would not seem to be any rea-
son to exclude data from the SPC services with low re-
sponse rates in future studies.
Methods
Patients and data
The Danish palliative database
All SPC services in Denmark deliver data to the Danish
Palliative Database (DPD) on patients referred to their
service. DPD contains information on all patients re-
ferred to SPC in Denmark from 2010 and onwards. Pa-
tient information recorded in DPD includes diagnosis,
socio-demographic factors, whether the patient has re-
ceived SPC, and the symptom/problems and QOL
among patients admitted to SPC. Data in this study was
obtained from the DPD.
Inclusion criteria
This study included data for patients who: 1) were ad-
mitted to SPC and died between January 1st, 2010 and
December 31st, 2015, 2) had a cancer diagnosis, 3) were
18+ years of age and 4) answered the EORTC QLQ-
C15-PAL questionnaire in the period from 3 days prior
to admission to the day of admission to SPC.
EORTC QLQ-C15-pal
The EORTC QLQ-C15-PAL questionnaire is a short-
ened version of the widely used EORTC QLQ-C30 de-
veloped for assessment of different aspects of quality of
life in cancer patients in palliative care, i.e., assessment
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of nine symptoms and problems and overall QOL [7].
EORTC QLQ-C15-PAL has four multi-item scales
(physical functioning, emotional functioning, fatigue and
pain) and six single-item scales (dyspnea, insomnia, ap-
petite loss, constipation, nausea/vomiting and overall
QOL) [7]. The patients answer on a 4-point scale how
much they have experienced the symptom/problem (not
at all, a little, quite a bit, very much), except for overall
QOL which is rated on a 7-point scale where 1 is very
poor and 7 excellent. The time frame is the past week
except for physical functioning for which no time-period
is specified.
Statistics
The analyses were performed using SAS statistical soft-
ware version 9.4.
Conversion of scale scores and computation of response
rate
The responses to the EORTC QLQ-C15-PAL were con-
verted into 0–100 scales according to the scoring man-
ual [8, 9]. For the two functional scales and QOL, higher
scores represent better functioning/QOL, whereas for
the seven symptom scales, higher scores represent worse
symptoms [8, 9].
The response rate was computed for each SPC service
for each calendar year. The response rate for a service a
given year was computed as the number of patients ad-
mitted to the service that year who completed the ques-
tionnaire at admittance divided by all the patients who
were admitted to the service the same year. A response
rate was allocated to each patient in the study. Thus, a
patient admitted to e.g., the Palliative Care Team in
Århus in 2010 was allocated the response rate of Pallia-
tive Care Team in Århus in 2010. Response rate was
grouped into; < 20.0%, 20.0–29.9%, 30.0–39.9%, 40.0–
49.9%, 50.0–59.9% and ≥ 60.0%.
Multiple linear regression
Multiple linear regression analyses were performed to
study the association between response rate and scale
scores. The ≥60.0% response rate group was used as ref-
erence since it was expected to have the least selection
bias.
The study hypothesis, i.e. that patients from SPC ser-
vices with low response rates had better scale scores on
the ten QOL aspects than patients from services with
high response rates (indicating possible selection bias),
was tested using four criteria:
1. The p-value for the overall association between
response rate and scale score was < 0.05.
2. The p-value for at least one pairwise comparison of
scale scores in lower response rates groups (<
20.0%, 20.0–29.9%, 30.0–39.9% 40.0–49.9%, 50.0–
59.9%) with the ≥60.0% response rate group was <
0.05.
3. The difference in scale score was in the direction
supporting our hypothesis (lower symptom score
and higher functioning and QOL in the lower
response rate groups compared to the ≥60.0%
group), and
4. The mean difference in scale scores had to be 5 or
more to be considered clinically relevant.
If one or more of the criteria were not fulfilled, the
study hypothesis was rejected. This was tested for the
scale scores of each of the ten QOL aspects.
The choice of 5 as a clinically relevant difference in
scale scores was based on results and conclusions from
previous studies [10–14]. In these studies, 10 is often
used as the clinically relevant cut point [15]. In this
study, the more conservative cut point of 5 was chosen
because it was important not to miss relevant
differences.
Adjustment and random effects in the regression analyses
The patients in this study were from either hospices or
palliative care teams. Previous studies have found more
symptoms, worse performance status and shorter sur-
vival time in hospice patients compared to patients from
other palliative care services [16–19]. We therefore con-
trolled for type of SPC service (hospice/team) in the re-
gression analyses. A random effect for SPC service was
also included in the model because patients from the
same SPC service were expected to be more similar than
patients from different SPC services. Further, a random
effect of patient id was included in the model to account
for the fact that some patients filled in more than one
questionnaire (if admitted to more than one service).
Choice of regression analysis method
The results of the association between response rate
and scale scores from the linear regression analyses
(mean differences in symptom score) are presented in
this article due to their simple interpretation. Linear
regression is, however, not the obvious choice for the
scales with only four (dyspnea, sleep, appetite loss,
constipation and nausea) or seven (pain, emotional
functioning and QOL) possible scores because the
normal distribution assumption is likely to be vio-
lated. Logistic regression (with symptom scores di-
chotomized at the median) with random effects was
therefore performed as a sensitivity analysis to ensure
that significant associations were not missed in the
linear regression analyses.
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Change in mean scale scores when excluding patients from
SPC services with response rates < 60.0%
In addition to the regression analyses we compared the
mean scale scores for the entire study sample with the
mean scores obtained when patients from services with
response rate < 20.0, < 30.0, < 40.0, < 50.0 and < 60.0%,
respectively, were excluded. Higher symptom/lower
functional scores in the reduced samples would support
the hypothesis of selection bias.
Results
Study population
The 40,316 adult Danish cancer patients in DPD who re-
ceived specialized palliative care and died between 2010
and 2015 had 49,307 admittances to SPC services (some
patients were admitted to more than one service). In 24,
589 (49.9%) of these patient admittances, based on 22,
420 patients, the EORTC QLQ-C15-PAL was answered.
These 24,589 admittances were included in this study.
Of the 24,589 SPC admittances, 49.0% represented
women and the average age was 68.5 years (Table 1).
Three of four (74.0%) of the SPC admittances were in a
palliative care team. The number of SPC admittances in-
creased from 2010 to 2014 but decreased from 2014 to
2015 (patients who died later than 2015 were not in-
cluded). The largest differences between patients
responding to the EORTC QLQ-C15-PAL questionnaire
(and thus included in the study) and non-respondents
was that the study population were less likely to be hos-
pice patients (26.0% vs. 47.9%) and their average survival
time was longer (94.0 vs. 64.5 days) compared to non-
respondents (Table 1).
Response rate
The patients were from 44 services, and each service ad-
mitted between 2 and 591 patients each year. The overall
response rate was 49.9% and varied between year and
service from 0.0 to 93.2% (Table 2).
Most patients were categorized in the response rate
group ≥60.0% but 42.3% were categorized in a lower
group, i.e. were admitted to a service having a response
rate below 60.0% in the year of admission (Table 1).
Are symptom scores biased in services with low response
rates?
The results of the multiple linear regressions are shown
in Fig. 1 and are summarized in Fig. 2. The results were
interpreted using the four criteria listed in the Methods
section.
Criterion 1. Significant associations with response rate
were found for six of the ten symptoms/problem scales
(dyspnea, appetite loss, fatigue, nausea, emotional func-
tion and physical function).
Criterion 2. Mean scores for the six symptoms/prob-
lems were compared between the ≥60.0% response rate
group and each of the five lower response rate groups
(< 20.0%, 20.0–29.9%, 30.0–39.9%, 40.0–49.9% and 50.0–
59.9%, respectively), i.e., in total 30 comparisons. In 13
of the 30 comparisons, a significant difference was found
between the ≥60.0% response rate group and the lower
response rate group.
Criterion 3. In two of these 13 comparisons, patients
from the lower response rate groups (20.0–29.9% and
30.0–39.0%) had better scores (higher mean physical
function) compared to the ≥60.0% response rate group,
in accordance with the study hypothesis.
The remaining 11 of the 13 significant comparisons
contradicted the study hypothesis as the patients from
the lower response rate group had worse symptoms/
problems. Thus, compared to the ≥60.0% response rate
group, the 30.0–59.9% response rate groups had worse
appetite loss, the 40.0–49.9% response rate group had
worse fatigue, the < 20.0–49.9% response rate groups
had worse nausea and the 20.0–59.9% response rate
groups had lower emotional function.
Criterion 4. For physical function, the 20.0–29.9% and
30.0–39.0% response rate groups had 1.9 and 1.7 point
higher mean physical function, respectively, compared to
the ≥60.0% response rate group and these differences
were therefore not clinically relevant. For the 11 signifi-
cant comparisons that were not in accordance with the
study hypothesis, only one was possibly clinically rele-
vant (patients from the < 20.0% response rate group re-
ported 5.7 point more nausea compared to patients from
the ≥60.0% response rate group).
Choice of regression analysis method
The linear regression analyses found more significant as-
sociations between response rates and scale scores than
the logistic regression analyses did, and thus the linear
regression analyses did not generally miss significant as-
sociations, except for QOL but in that case the logistic
regression analysis did not find systematically worse (or
better) QOL in the lower response rate groups com-
pared to the highest response rate group (Table 3).
Change in mean scale scores when patients from SPC
services with response rates < 60.0% are excluded.
The mean scale scores were almost identical for the
whole population and the sub-populations with exclu-
sion of the < 20.0, < 30.0, < 40.0, < 50.0 and < 60.0% re-
sponse rate groups, respectively. The largest change in
mean score after exclusion of the lower response rate
groups was 2.0 (in emotional function, range 0–100)
(Fig. 3). Thus, removing patients from services with
lower response rates from the mean scale score calcula-
tions had almost no effect on the mean scores.
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Table 1 Characteristics of the study population (i.e., those who answered the EORTC QLQ-C15-PAL at the start of palliative care) and
non-respondents
Answered EORTC QLQ-C15-PAL
Yes No
N % N %
All 24,589 100 24,718 100
Age
Mean 68.5 69.2
Median 69 70
Range 19–101 18–105
Gender
Women 12,150 49.4 12,695 51.4
Men 12,439 50.6 12,023 48.6
Cancer site/diagnosis
Head and neck 765 3.1 730 3.0
Esophagus 844 3.4 738 3.0
Stomach 772 3.1 700 2.8
Small Intestine 177 0.7 160 0.7
Colon and rectum 2984 12.1 2795 11.3
Liver and intrahepatic bile ducts 828 3.4 887 3.6
Pancreas 1878 7.6 1735 7.0
Lung, bronchus and trachea 6381 26.0 6250 25.3
Melanoma 518 2.1 549 2.2
Breast 2003 8.2 1986 8.0
Cervix 248 1.0 246 1.0
Uterus 277 1.1 311 1.3
Ovary 886 3.6 870 3.5
Prostate 1843 7.5 1629 6.6
Bladder 617 2.5 710 2.9
Kidney, renal pelvis, ureter 753 3.1 700 2.8
Brain and central nervous system 637 2.6 1091 4.4
Lymphoma 158 0.6 225 0.9
Myelomatosis 205 0.8 210 0.9
Leukaemia 225 0.9 331 1.3
Sarcomas and other soft tissues 298 1.2 281 1.1
Other cancer site 767 3.1 831 3.4
Unknown cancer site 525 2.1 753 3.1
Specialized palliative care service
Palliative care teams 18,207 74.0 12,880 52.1
Hospice 6382 26.0 11,838 47.9
Survival time from start of specialized palliative care to death (days)
Mean 94.0 64.5
Median 42 20
Range 0–2126 0–2101
Year of admission
2010 2716 11.0 4172 16.9
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Discussion
Evidence supporting selection bias in SPC services with
low response rates?
Our aim was to test whether the response rate was asso-
ciated with scale scores of ten quality of life aspects. By
doing this we could test the study hypothesis, i.e. that
patients from SPC services with low response rates were
reporting better QOL than patients from services with
high response rates, indicating possible selection bias in
services with low response rates. Such selection bias
could happen if the health care professional in low re-
sponse services had primarily asked the most well pa-
tients to answer the EORTC QLQ-C15-PAL
questionnaire, leading to an overestimation of the QOL
in the low response services which would result in better
scores on the ten QOL aspects (lower symptom scores
and higher function and overall QOL scores) in these
low response services compared to high response ser-
vices where patients were not selected (or less selected).
On the other hand, if patients in low response services
were randomly asked to answer the EORTC QLQ-C15-
PAL questionnaire the QOL would be representative for
the patients in the low response service. This would
likely result in similar QOL scores in the low and high
response services or perhaps worse scores in the low re-
sponse services if the explanation to the lower response
rate was a sicker patient population. Thus, to accept the
study hypothesis, the score of one or more of the quality
Table 1 Characteristics of the study population (i.e., those who answered the EORTC QLQ-C15-PAL at the start of palliative care) and
non-respondents (Continued)
Answered EORTC QLQ-C15-PAL
Yes No
2011 3400 13.8 4528 18.3
2012 4364 17.7 4164 16.8
2013 4929 20.0 4054 16.4
2014 5019 20.4 4076 16.5
2015 4161 16.9 3724 15.1
Response ratea
< 20% 602 2.5 5501 22.3
20.0–29.9% 1282 5.2 3957 16.0
30.0–39.9% 2145 8.7 4183 16.9
40.0–49.9% 2926 11.9 3537 14.3
50.0–59.9% 3442 14.0 2795 11.3
≥ 60.0% 14,192 57.7 4745 19.2
Number of questionnaires completed per patientb
1 20,285 90.5 – –
2 2102 9.4 – –
3 32 0.1 – –
4 1 0.0 – –
EORTC scale-scores (mean, range)
Pain 56.4 (0.0–100.0) – –
Dyspnea 58.0 (0.0–100.0) – –
Sleeplessness 37.0 (0.0–100.0) – –
Appetite loss 58.3 (0.0–100.0) – –
Constipation 33.3 (0.0–100.0) – –
Fatigue 75.9 (0.0–100.0) – –
Nausea/vomiting 24.8 (0.0–100.0) – –
Emotional function 64.8 (0.0–100.0) – –
Physical function 27.4 (0.0–93.3) – –
Overall quality of life 39.0 (0.0–100.0) – –
a Response rate was computed according to SPC service and calendar year. Thus, a patient admitted to an SPC service in 2012 was allocated the response rate of
that SPC service for 2012. bOnly one questionnaire could be completed per SPC admittance and if patients were admitted more than once to the same SPC
service, only the first was included
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Table 2 Number of patients admitted to SPC and response rate by admission year and overall (N = 49,307)
Year of admittance to specialized palliative care (SPC)
2010 2011 2012 2013 2014 2015 Total
SPC service N RR N RR N RR N RR N RR N RR N RR
Anker Fjord Hospice 115 26.1 159 46.5 163 46.0 167 78.4 161 86.3 173 52.0 938 57.5
Arresødal Hospice 175 0.0 186 0.0 161 3.7 209 15.8 204 20.1 170 18.8 1105 10.1
Diakonissestiftelsens Hospice 204 12.7 223 22.9 189 31.2 188 45.2 169 63.9 153 48.4 1126 35.8
Gudenå Hospice NE NE NE NE NE NE NE NE NE NE 74 20.3 74 20.3
Hospice Djursland 196 43.4 172 47.7 186 46.8 204 44.1 220 51.4 186 33.3 1164 44.6
Hospice Filadelfia 136 75.7 163 76.1 194 80.9 169 68.6 182 62.6 160 72.5 1004 72.7
Hospice Fyn 131 30.5 171 34.5 159 40.3 121 26.4 124 20.2 117 18.8 823 29.4
Hospice Limfjorden 146 38.4 141 34.0 173 32.4 190 38.4 173 54.9 171 56.7 994 42.8
Hospice Sjælland 10 0.0 186 0.0 183 33.9 201 18.9 266 15.8 243 13.2 1089 16.0
Hospice Sydfyn NE NE NE NE 24 33.3 137 30.7 173 37.0 127 55.1 461 39.9
Hospice Sydvestjylland 145 0.0 139 18.0 149 12.8 126 11.9 160 27.5 145 29.0 864 16.8
Hospice Søholm 114 0.9 134 2.2 149 8.7 142 24.6 144 47.9 122 38.5 805 20.9
Hospice Sønderjylland 107 56.1 130 51.5 149 58.4 135 25.9 122 27.0 112 43.8 755 43.8
Hospice Vendsyssel 76 0.0 89 0.0 89 0.0 122 0.8 119 12.6 134 9.7 629 4.6
Kamilianergaarden Hospice 141 2.1 190 7.9 172 11.6 179 30.2 179 43.0 154 47.4 1015 23.8
PCT Bispebjerg 378 31.7 401 30.2 345 32.5 363 25.6 341 44.0 285 57.2 2113 35.9
PCT Herlev 70 72.9 70 84.3 107 69.2 297 74.4 353 62.9 337 54.6 1234 65.7
PCT Herning 166 38.0 151 47.0 176 56.8 181 63.5 208 67.3 191 54.5 1073 55.3
PCT Himmerland 54 7.4 174 40.2 172 71.5 178 77.0 198 67.7 224 78.1 1000 64.3
PCT Holbæk 122 13.9 90 45.6 94 64.9 87 70.1 70 54.3 88 50.0 551 47.5
PCT Horsens NE NE 59 64.4 144 82.6 133 93.2 210 75.7 161 56.5 707 75.1
PCT Hvidovre NE NE 4 0.0 138 41.3 242 66.1 171 63.7 156 64.1 711 59.9
PCT Køge 60 3.3 101 17.8 98 69.4 91 63.7 64 81.3 20 90.0 434 49.8
PCT Nordsjælland 239 51.0 209 67.5 225 77.3 244 74.6 234 70.1 161 71.4 1312 68.4
PCT Nykøbing 194 66.5 206 76.7 204 75.0 194 82.5 193 71.0 179 82.1 1170 75.6
PCT Næstved 200 69.5 222 71.6 182 79.1 220 83.2 257 81.3 203 76.4 1284 77.0
PCT Odense 271 52.0 429 54.1 533 59.3 568 52.1 591 49.7 459 47.7 2851 52.5
PCT Randers 182 71.4 189 83.6 246 87.8 251 86.1 261 91.6 209 87.1 1338 85.3
PCT Rigshospitalet 96 28.1 122 27.0 95 32.6 84 69.0 97 76.3 63 73.0 557 48.3
PCT Roskilde 146 63.0 155 61.3 211 65.9 215 55.8 213 63.8 200 71.0 1140 63.5
PCT Silkeborg 169 66.9 190 86.8 179 81.6 174 93.1 136 84.6 104 79.8 952 82.4
PCT Slagelse 150 71.3 166 77.7 162 83.3 172 87.2 198 81.3 159 72.3 1007 79.1
PCT Sydvestjysk Sygehus 134 79.1 136 88.2 154 87.7 156 78.8 196 67.9 139 79.9 915 79.6
PCT Sønderjylland 257 45.5 271 59.4 315 67.9 279 74.2 252 71.0 197 59.4 1571 63.3
PCT Thy-Mors 167 16.2 164 0.0 169 75.1 191 65.4 148 36.5 121 39.7 960 39.7
PCT Vejle 267 89.1 230 85.7 215 77.7 217 72.8 264 66.7 195 60.5 1388 75.9
PCT Vendsyssel 55 0.0 280 10.7 337 21.7 284 38.4 282 42.9 274 20.4 1512 25.7
PCT Viborg 510 26.7 191 73.8 189 66.7 178 70.2 165 78.8 113 83.2 1346 55.9
PCT Ålborg 436 31.4 455 28.4 391 28.6 422 43.1 377 35.5 326 47.9 2407 35.3
PCT Århus 335 35.2 331 41.1 381 44.4 307 58.0 280 54.3 211 56.4 1845 47.3
Skt. Lukas Hospice 290 11.7 410 17.3 399 20.6 347 20.2 327 30.3 290 34.1 2063 22.1
Skt. Maria Hospice 110 83.6 93 89.2 142 89.4 160 77.5 158 53.8 144 73.6 807 76.5
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of life aspects should be significantly better (i.e., lower
symptom score, higher function score, higher overall
QOL score) in palliative care services with low response
rates compared to patients from services with high re-
sponse rates. However, results from the multiple linear
regression analyses did not support the study hypothesis:
there were overall associations between response rate
and six out of ten QOL scale scores. However, within
these six scales, only two out of 30 comparisons were
significant and in the expected direction. The magnitude
of these comparisons was very small (below 2 on a 0–
100 scale) and thus not clinically relevant. Furthermore,
mean scale scores in the whole population were almost
identical to mean scale scores calculated after exclusion
of the < 20.0, < 30.0, < 40.0, < 50.0 and < 60.0% response
rate groups, respectively, supporting that the response
rate had neglectable impact on the scale scores. This is
in accordance with findings from a previous, much
smaller study in patients with advanced cancer, where
no evidence of clinically relevant difference in the quality
of life scores due to non-participation was found [6].
There were some cases where patients from services
with low response rates reported significantly worse
QOL, and not better QOL as hypothesized. The differ-
ences were relatively small (1.8–5.7 on a 100-point scale)
and due to the large number of statistical test performed,
Table 2 Number of patients admitted to SPC and response rate by admission year and overall (N = 49,307) (Continued)
Year of admittance to specialized palliative care (SPC)
2010 2011 2012 2013 2014 2015 Total
Svanevig Hospice 132 37.9 121 41.3 155 27.1 178 14.0 160 31.3 188 37.2 934 30.7
Søndergård Hospice 2 0.0 225 20.4 230 47.4 280 81.1 295 65.8 247 60.7 1279 56.8
Total 6888 39.4 7928 42.9 8528 51.2 8983 54.9 9095 55.2 7885 52.8 49,307 49.9
RR Response rate, NE Non-existing data because the service did not exist in that year, PCT Palliative care team/service in a hospital
Fig. 1 Association between response rate (≥60.0% is reference) and QOL scores from multiple linear regression analyses. Analyses adjusted for
type of SPC service (hospice vs. palliative care team) and with random effect of patient id and SPC service. CL = confidence limit, MD =mean
difference. For the symptom scales, a negative MD means that the < 60.0% response rate groups have lower symptom scores than the ≥60.0%
response rate group. For functional and QOL scales, a positive MD means that the < 60.0% response rate groups have higher functioning/QOL
than the ≥60.0% response rate group. Blue dotted lines show the minimum level for clinically relevant mean differences. *Overall p-value for the
association between response rate and scale score was < 0.05. **P-value for difference in symptom score between the ≥60.0% response rate
group and one of the lower response rate groups was < 0.05
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these findings may be due to chance. It is however not un-
likely that non-response is associated with poor health [4,
5] and the slightly worse symptom/problem scores in SPC
services with low response rates may reflect a slightly
more ill patient population in SPC services with low re-
sponse rates, i.e. not selection bias.
Strengths and weaknesses
There are several strengths in this study. First, it is based
on a large dataset with national coverage including data
from all SPC services in Denmark. Second, the possibility
that different SPC services may not have the same com-
position of patients (due to socio-demographic or other
differences across referral areas) was accounted for by in-
cluding the random effect of specific SPC service.
No services had complete data, which is a limitation for
at least two reasons. First, because our conclusion that
there is not more selection bias in SPC services with low
response rates than in those with ≥60.0% response rate is
not a full investigation of the possibility of selection bias
in SPC services with low response rates. However, due to
the nature of SPC, which is provided to patients with very
Fig. 2 Graph showing how the study hypothesis is tested in the study according to four criteria. *S/Ps = the nine symptoms/problems and
overall QOL. **A ‘case’ for each pairwise comparison of S/P mean scores between the ≥60.0% response rate group and a lower response rate
group, i.e. five comparisons for each S/P
Table 3 P-values for the association between response rate and symptom scores in linear and logistic regression
PA DY SL AP CO FA NV EF PF QOL
Linear 0.11 0.02 0.10 < 0.01 0.53 0.04 < 0.01 < 0.0001 < 0.01 0.19
Logistic 0.96 0.46 0.27 0.10 0.66 < 0.01 0.01 < 0.01 0.01 0.03
Analyses adjusted type of SPC service (hospice vs. palliative care team) and with random effect of SPC service and patient id
PA Pain (N = 24.482), DY Dyspnea (N = 24.255), SL Sleeplessness (N = 24.256), AP Appetite loss (N = 24.272), CO Constipation (N = 24.061), FA Fatigue (N = 23.698), NV
Nausea (N = 24,291), EF Emotional function (N = 23,018), PF Physical function (N = 24,056), QOL Quality of life (N = 21,043)
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advanced disease and short survival, it will probably not
be possible to achieve much higher response rates than
achieved in the best performing services. Second, it is im-
possible to know whether differences in scale scores be-
tween SPC services with high and low response rates are
in fact do to selection bias in SPC services with low re-
sponse rates or whether they are caused by SPC services
with low response rates actually having different scale
scores, since we do not know the true scale scores. Thus,
looking at difference in scale scores between SPC services
with low and high response rates is only one way to at-
tempt to decide whether selection bias seems plausible in
services with low response rates, and the fact that we
found no major impact is reassuring.
Future research
Only a few large studies (1000–2000 patients) have looked
at symptom prevalence or symptom levels in patients at the
start of palliative care [17, 20, 21] and to our knowledge this
is the first European study to report data from all services
in a whole country. Given that the present study indicates
that our full data set can be used for analysis without any
major risk of impact of selection bias, future analyses can
safely be made at the national level to investigate the symp-
toms/problems and QOL among patients admitted to SPC.
Conclusion
The study hypothesis – that patients from SPC services
with lower response rates have better scores on different
QOL aspects than those from SPC services with high re-
sponse rates due to selection bias in services with low
response rates - was not supported. Therefore, there
does not seem to be any reason to exclude data from
SPC services with low response rates in future studies of
national data sets.
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